Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.
Key claim: Biological age acceleration (PhenoAge, KDM-BA) and frailty are inversely associated with macular thickness in over 45,000 UK Biobank participants, with plasma metabolic signatures mediating a substantial share of these associations and adverse exposomes acting through aging and metabolic pathways.
Abstract
Systemic aging alters ocular structures and plasma metabolome, yet relationships between multidimensional biological aging, environmental exposomes, plasma metabolism, and retinal changes remain uncharacterized. This study evaluated how these phenotypic networks align with retinal structural variations. Following rigorous screening, 45,542 UK Biobank participants (2006-2010) were analyzed. Systemic aging was quantified using PhenoAge acceleration, Klemera-Doubal method age acceleration (KDM-BA), and a frailty index (FI). Plasma metabolic signatures were derived from nuclear magnetic resonance profiling via elastic net regression, and exposome factors (lifestyle, diet, pollution, mental health) were assessed via phenotypic data. Mediation analyses evaluated the intermediary roles of plasma metabolites. Biological age acceleration and frailty showed significant inverse associations with macular thickness across all inner subfields (standardized β range -1.386 to -0.421, all FDR-adjusted P < 0.001). Metabolic signatures accounted for substantial proportions of these associations: 81.14% for PhenoAge acceleration, 19.92% for KDM-BA acceleration, and 32.27% for FI (all FDR-adjusted P < 0.001). Integrative analyses demonstrated that adverse exposomes-including tobacco exposure, poor diet, air pollution, and negative psychosocial states-correlated with reduced macular thickness, with systemic aging and metabolic dysregulation serving as significant statistical intermediaries within these multidimensional pathways. These findings demonstrate a robust link between systemic senescence and retinal structure, suggesting that plasma metabolism is a key correlate of neurosensory retinal integrity.
Why this matters
Macular thickness measured on routine OCT is being proposed as a cheap, non-invasive window on systemic aging — but that only matters if it tracks established aging metrics in large populations. This UK Biobank analysis shows PhenoAge, KDM-BA, and frailty each move with macular thinning in the same direction and that plasma metabolites carry a substantial fraction of the signal, which supports treating the retina as a convergence point for molecular and functional aging markers rather than an isolated ocular finding. Mediation does not prove the retina is being aged by metabolism; it maps where in the causal chain the correlation sits.